CIK: 1540188 - Address: C/o Cerevel Therapeutics Holdings, Inc., 222 Jacobs Street, Suite 200, Cambridge, MA 02141
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret116136-3-5-5-1
S%wins5017083505042

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/27/23 16:15
12/22/23
CERECerevel Therapeutics Holdings, Inc.DEHealthDrugPharmaceutical PreparationsDipietro KennethMAOCHROS.d-33241.450-8-2425D
12/21/23 20:24
12/20/23
CERECerevel Therapeutics Holdings, Inc.DEHealthDrugPharmaceutical PreparationsDipietro KennethMAOCHROS.d-25941.420-6-2025D
3/17/15 20:10
3/16/15
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagDipietro KennethMAOEVP HRS-334415.4633-1-1000D13827302384-13091-9-26-42
2/18/15 16:37
2/17/15
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagDipietro KennethMAOEVP HRS-462389.1133-1-601D1422116251811-12117-1-21-34
2/3/15 18:35
2/2/15
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagDipietro KennethMAOEVP HRS-644389.0333-2-1000D15025182110121011-115-2-18-33
2/14/14 16:36
2/13/14
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagDipietro KennethMAOEVP HRS.d-409316.8133-1-1000D17898553917873265-12319
2/5/14 16:36
2/4/14
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagDipietro KennethMAOEVP HRS-495299.0133-2-1000D154983527942-30613-5830
10/2/13 13:36
9/30/13
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagDipietro KennethMAOEVP HRS-348242.0033-1-1000D158632513194-111-82142632

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact